Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria

Journal: Nature Communications

Published: 2020-06-10

DOI: 10.1038/s41467-020-16731-6

Affiliations: 3

Authors: 17

Go to article
Institutions Share
Jichi Medical University, Japan 0.82
University of Glasgow, United Kingdom (UK) 0.12
National Institute of Infectious Diseases (NIID), Japan 0.06

Return